The invention provides a method of treating a mammal having, or at risk of, an indication associated with a TGF-beta deficiency comprising administering one or more agents that is effective to elevate the level of TGF-beta. The invention also provides novel compounds that elevate TGF-beta levels, as well as pharmaceutical compositions comprising compounds that elevate TGF-beta levels, and methods for detecting diseases associated with endothelial cell activation.
本发明提供了一种治疗哺乳动物的方法,该哺乳动物具有或有可能具有与 TGF-beta 缺乏有关的适应症,该方法包括施用一种或多种能有效提高 TGF-beta
水平的制剂。本发明还提供了能提高TGF-beta
水平的新型化合物、包含能提高TGF-beta
水平的化合物的药物组合物,以及检测与内皮细胞活化相关的疾病的方法。